NCT01542424View on ClinicalTrials.gov

An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

1,889

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 30

Prescribed at the discretion of the physician

DRUG

insulin detemir

Prescribed at the discretion of the physician

Trial Locations (1)

MK-1000

Novo Nordisk Investigational Site, Skopje

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY